<unk> , although rare, is the third most common glioma. In adults, it constitutes about 9.4% of all primary brain and central nervous system tumors and 5%–18% of all glial neoplasms. The incidence of<unk>  and anaplastic<unk>  is estimated to be 0.32 and 0.17 cases per 100,000 individuals in the United States, respectively.<unk>  tends to affect the middle-aged adult population, most commonly occurring in the 4th and 5th decade of life. Median age at the time of diagnosis of<unk>  is 35-47 years. Males are more commonly affected with<unk>  than femaleswith male to female ratio being approximately 1.3:1.<unk>  usually affects individuals of the Caucasian race. African American, Latin American, and Asian individuals are less likely to develop<unk> .
Oligodendroglioma epidemiology and demographics
Oligoastrocytoma epidemiology and demographics
Ependymoma epidemiology and demographics
Ameloblastoma epidemiology and demographics
Oligodendroglioma classification
Meningioma epidemiology and demographics
Glioblastoma multiforme epidemiology and demographics
Astrocytoma epidemiology and demographics